Fresh from Reuters——
Just as worldwide shortages of masks and disinfectant gels have pushed up the prices of those products, single-use medical gloves have become increasingly difficult and costly to come by during the health crisis and this effect is multiplied with closure of the largest Top Glove factory due to EMCO.

Malaysian manufacturer Top Glove, which describes itself as the world's biggest producer of rubber gloves, said it is seeing orders for 24-30 billion a month, compared with 4.5 billion prior to the pandemic has complied to government’s order.

Top Gloves is the world's biggest maker of rubber gloves, accounting for around 25 per cent of global exports. And according to the Malaysian manufacturers' association MARGMA, worldwide demand is projected to rise from 330 billion in 2020 to 590 billion in 2021 due to mass vaccination campaign. With the closure of largest factory and rising demand, given the surge, the industry is forecasting a massive shortage of gloves that is expected to last well into 2023 and ASP will increase 3 folds to 70% month (current 25%) on month basis, MARGMA said.
.

Confirmed in TV3 nightline news on closure of Top glove factory in Klang where their 13k workers there will be placed under EMCO for 2 weeks. Supply of gloves will be impacted globally because TG supply 1 of every 4 gloves. With that, ASP will shoot up. Supply is lesser and increasing demand Because countries require glove for immunisation program next year. Higher ASP means higher profit for Kossan.

https://www.google.com.my/amp/s/finance.yahoo.com/amphtml/news/pfizer-inc-pfe-chairman-ceo-001511415.html

https://www.google.com.my/amp/s/finance.yahoo.com/amphtml/news/pfizer-inc-pfe-chairman-ceo-001511415.html

Unlucky margin call to some big timers. With this news, pretty sure a V shape rebound Tomorrow.

https://www.google.com.my/amp/s/www.bloomberg.com/amp/news/articles/2020-11-10/brazil-pauses-trial-of-china-vaccine-after-serious-adverse-event

Dr. Scott Gottlieb told CNBC the U.S. will still have to experience “the hardest stretch” of the coronavirus pandemic without the benefits of a vaccine, despite the positive news earlier Monday from Pfizer.

Gottlieb, a former U.S. Food and Drug Administration commissioner in the Trump administration, is a member of Pfizer’s board of directors.

Dr. Scott Gottlieb told CNBC the U.S. will still have to experience “the hardest stretch” of the coronavirus pandemic without the benefits of a vaccine, despite the positive news earlier Monday from Pfizer.

Gottlieb, a former U.S. Food and Drug Administration commissioner in the Trump administration, is a member of Pfizer’s board of directors.

Dr. Scott Gottlieb told CNBC the U.S. will still have to experience “the hardest stretch” of the coronavirus pandemic without the benefits of a vaccine, despite the positive news earlier Monday from Pfizer.

Gottlieb, a former U.S. Food and Drug Administration commissioner in the Trump administration, is a member of Pfizer’s board of directors.

Dr. Scott Gottlieb told CNBC the U.S. will still have to experience “the hardest stretch” of the coronavirus pandemic without the benefits of a vaccine, despite the positive news earlier Monday from Pfizer.

Gottlieb, a former U.S. Food and Drug Administration commissioner in the Trump administration, is a member of Pfizer’s board of directors.

There are questions about how long immunity lasts, and about vaccine's effectiveness for different age groups.
The data presented is not the final analysis. It is based on the first 94 volunteers to develop Covid - the precise effectiveness of the vaccine may change when the full results are analysed.
Pfizer and BioNTech say they will have enough safety data by the third week of November to take their vaccine to regulators. Until then it is not possible for countries to begin their vaccination campaigns. It is a relief... there is a long long way to go before vaccines will start to make a real difference, but this feels to me like a watershed moment.

There are questions about how long immunity lasts, and about vaccine's effectiveness for different age groups.
The data presented is not the final analysis. It is based on the first 94 volunteers to develop Covid - the precise effectiveness of the vaccine may change when the full results are analysed.
Pfizer and BioNTech say they will have enough safety data by the third week of November to take their vaccine to regulators. Until then it is not possible for countries to begin their vaccination campaigns. It is a relief... there is a long long way to go before vaccines will start to make a real difference, but this feels to me like a watershed moment.

There are questions about how long immunity lasts, and about vaccine's effectiveness for different age groups.
The data presented is not the final analysis. It is based on the first 94 volunteers to develop Covid - the precise effectiveness of the vaccine may change when the full results are analysed.
Pfizer and BioNTech say they will have enough safety data by the third week of November to take their vaccine to regulators. Until then it is not possible for countries to begin their vaccination campaigns. It is a relief... there is a long long way to go before vaccines will start to make a real difference, but this feels to me like a watershed moment.

There are questions about how long immunity lasts, and about vaccine's effectiveness for different age groups.
The data presented is not the final analysis. It is based on the first 94 volunteers to develop Covid - the precise effectiveness of the vaccine may change when the full results are analysed.
Pfizer and BioNTech say they will have enough safety data by the third week of November to take their vaccine to regulators. Until then it is not possible for countries to begin their vaccination campaigns. It is a relief... there is a long long way to go before vaccines will start to make a real difference, but this feels to me like a watershed moment.

Global Nitrile Disposable Gloves Market Research Report: Detailed Report Of The Global Market During The COVID-19 Pandemic From Spire Market Research

COVID-19 on Nitrile Disposable Gloves Market research report provides a detailed analysis and important factors affecting the progress of the global market. The Nitrile Disposable Gloves Market research report covers different subjects such as types of products, Nitrile Disposable Gloves market size & share, major market catalysts & restraints, applications, growth opportunities, challenges, Nitrile Disposable Gloves competitive landscape, and major players.

Inquire for this report @: https://spiremarketresearch.com/report/global-nitrile-disposable-gloves-market-224322#inquiry-for-buying

Top players of the Global Nitrile Disposable Gloves Market studied in the report are:

Top Glove
Kossan
Harta
Kanam Latex
Comfort Rubber Gloves Industries
Tan Sin Lian
Shandong Yuyuan
Zhangjiagang Dayu
Shandong Xingyu
Anhui Haojie
Suzhou Colour-way

The Nitrile Disposable Gloves report contains important factors and points, such as end user and type as well as a plethora of segments that decide the prospects of global Nitrile Disposable Gloves market. Every segment offers data regarding the business esteem during the Nitrile Disposable Gloves market forecast period. In the same manner, the application segment offers data by consumption and volume during the forecasted period. The covide-19 Nitrile Disposable Gloves comprehension of this section directs the readers in distinguishing the importance of variables that help expand the global Nitrile Disposable Gloves market.

The global Nitrile Disposable Gloves market report begins with an overview of the global market in which evaluate and highlights of products are described. In addition to Nitrile Disposable Gloves this report, the segment offers alertness of some major factors of the global Nitrile Disposable Gloves market. Highlights of the segmentation comprise of sales, price, sales growth rate, income, and share of the market by product.

In addition to this, the Nitrile Disposable Gloves report also covers competitive side of the market by sales, price, market share, and income with the help of Nitrile Disposable Gloves market rate, company, present day trends, expansion, merger, market stocks, and acquisition of major companies.

Get a sample copy of the report to understand the structure of the complete report: https://spiremarketresearch.com/report/global-nitrile-disposable-gloves-market-224322#request-sample

Moreover, the global Nitrile Disposable Gloves market report also contains detailed analysis of major players as well as a few helpful facts on their commercial enterprise. The Nitrile Disposable Gloves reports provides approximately the price, gross margin, products, revenue, and their specifications, applications, type, Nitrile Disposable Gloves industry manufacturing base, competitors, and the principle commercial enterprise of major companies active within the global Nitrile Disposable Gloves market.

Furthermore, this covide-19 analysis Nitrile Disposable Gloves report also contains sales, gross margin, market share, production, Nitrile Disposable Gloves market size, and CAGR within different regions all over the world. Here, the global Nitrile Disposable Gloves market is analyzed deeply on the basis of countries and areas together with Europe, Japan, North America, India, China, and the MEA.

Last, but not the least, the global Nitrile Disposable Gloves market report showcases important data about the global market. In order for the users to understand the data clearly and easily, the Nitrile Disposable Gloves report presents important data in the form of table and pictorial representations such as charts and diagrams. This helps users and clients to make informed decision as the statistics are understood easily.

Apple12345– Don’t get me wrong but you should not join since you discourages Kossan.. what’s your intention for being here? Get out.. by the way I have seen your feud with supersing and at first I do not want to intervene but your presence here is disturbing. And I’m not supersing. Just get out FGS

Be a good boy 12345apple

Apple12345 have you bought Kossan?? Listen to sifu here,

I heard ASP will increase massively in Oct due to shortages. The Gloves companies are not charity organisation hence, they look for best values from consumers

Apple 12345- where r u??

Congrats to all whom have bought low. Never listen to anti-kossan ppl. He was WRONG

Apple1234.. where are you? Anti kossan buyer must not comment here

When asked if Top Glove could become the largest listed company on Bursa Malaysia in terms of market capitalisation, Lim replied, “Of course, we will have a chance … there is a high possibility.

“Following the announcement of our financial results on Sept 17, we believe our market cap could overtake Malayan Banking Bhd (Maybank) and Public Bank Bhd by end-September or early October.”

Apple12345 how are you?

Vaccine maker warns it could take until 2024 to vaccinate everyone

The world's largest vaccine maker, Serum Institute, says it may take until 2024 to get everyone a Covid-19 vaccine if the vaccine requires two doses. CNN's Athena Jones reports.

Apple12345, what’s new?

Kossan is the best comparing to supermax and TG

Apple1234 ur supermx is leader in decline again today why lor?

Shut the f*ck up la seisohai apple12345what knowledge...your stupidity tell people chase high now supermax and topglove sinking like titanic ha ha ha ha !

To all Kossan haters Eg. Apple12345, Sooncafe:

There are only 3 kind of ppl who talk negative about Kossan:
1. lost money in the past in this counter.
2. try to make ppl panic sell to push down the price so that they get buy cheap
3. try to persuade others to invest in his already bought counter-TG or Supermax

if I'm none of above 3... i wont come in here to be spoiler like apple12345

To all Kossan haters Eg. Apple12345:

There are only 3 kind of ppl who talk negative about Kossan:
1. lost money in the past in this counter.
2. try to make ppl panic sell to push down the price so that they get buy cheap
3. try to persuade others to invest in his already bought counter-TG or Supermax

if I'm none of above 3... i wont come in here to be spoiler like apple12345

TG share- too much publicity and its price is overvalued. TS Lim too protective of its share price hence this caused overvaluation whereas Kossan’s price is based on pure fundamental EPS. Price you are paying for TG is premium, so it won’t go far. Market is irrational and if ppl think history repeats itself, then you are wrong. To all TG supporters out there, jump to Kossan.

Joyvest. You r right. These ........ uses this group to promote other stocks. Really dunno what’s their intention

Sell Supermax now. Buy Kossan.. @apple 12345. This guy has been supporting supermax and TG. Dunno for what it exist in this group

Sell supermax

Run run Supermax

Time to sell TG and Supermax. Both have been on a good run but seriously doubt, fundamentally

Apple 12345 I support you not

I heard a good news coming today. Buy or hold

Just as you think all is well with Vaccine trial. A trial is a trial— AstraZeneca pauses coronavirus vaccine trial after unexplained illness in volunteer. Drug giant AstraZeneca said Tuesday it had paused a trial of its coronavirus vaccine because of an unexplained illness in one of the volunteers.

It’s a standard precaution in vaccine trials, meant to ensure experimental vaccines don’t cause serious reactions among volunteers.

“As part of the ongoing randomized, controlled global trials of the Oxford coronavirus vaccine, our standard review process triggered a pause to vaccination to allow review of safety data,” the company said in a statement sent to CNN.
“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials,” the statement added.

Apple12345- go away pls.

Apple1234.. go away

apple1234, pang72– negative energy already went off!!

pang72- pls go away.. everyone, pls ask pang72 to leave

Global fund managers are buying. They are allowed to buy as this stock has just joined MSCI. Let’s join before too late.

My target price remain at 32.5. Achievable in within 3-4 months time

Omg bonus issue.. thanks !!!!!!must buy more

Wow!! Insider news 300 mil Pbt.

Lol EPF bought Kossan. Time to buy

My estimate is simple. Take 5 cents profit for every glove sold hence, 5*28bil= 1.4 Bil. It based on a very conservative parameter whereby 10%ASP/ month and efficiency coefficient are excluded from this calculation. With that, Kossan is expected to deliver 350 mil per quarter or eps of 30 cents per quarter. Supermax has proved that and the question is whether Kossan can deliver that and my answer to that is yes.. why? Because past and all Kossan vs Supermax quarterly results had demonstrated that. Kossan is more efficient amongst the big 4